|
Quotes & Info
|
| UTHR > SEC Filings for UTHR > Form 8-K/A on 29-Apr-2009 | All Recent SEC Filings |
29-Apr-2009
Change in Directors or Principal Officers
Explanatory Note Regarding This Amendment:
This Amendment No. 1 to the Form 8-K originally filed by United Therapeutics Corporation (the "Company") with the Securities and Exchange Commission on March 6, 2009 (the "Form 8-K"), is being filed in order to correct errors contained in the Form 8-K. No other changes have been made to the Form 8-K.
The corrections are as follows:
The Form 8-K reported that Dr. Roger Jeffs' annual base salary remains unchanged at $675,000. Dr. Jeffs' annual base salary remains unchanged at $710,000.
The Form 8-K reported that Mr. Paul Mahon's annual base salary remains unchanged at $585,000. Mr. Mahon's annual base salary remains unchanged at $615,000.
|
|